Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
Lantheus Reports First Quarter 2024 Financial Results
2 May 24
8-K
Departure of Directors or Certain Officers
29 Apr 24
ARS
2023 FY
Annual report to shareholders
15 Mar 24
DEFA14A
Additional proxy soliciting materials
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 24
8-K
Regulation FD Disclosure
26 Jan 24
8-K
Lantheus Announces CEO Succession Plan
23 Jan 24
8-K
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
9 Jan 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Lantheus Reports Third Quarter 2023 Financial Results
2 Nov 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Other Events
18 Aug 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Lantheus Reports Second Quarter 2023 Financial Results
3 Aug 23
SD
Conflict minerals disclosure
31 May 23
S-8
Registration of securities for employees
16 May 23
8-K
Entry into a Material Definitive Agreement
4 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Lantheus Reports First Quarter 2023 Financial Results
4 May 23
8-K
Departure of Directors or Certain Officers
1 May 23
8-K/A
Lantheus Announces Two Key Executive Promotions
17 Mar 23
8-K
Lantheus Announces Two Key Executive Promotions
17 Mar 23
ARS
2022 FY
Annual report to shareholders
17 Mar 23
DEFA14A
Additional proxy soliciting materials
17 Mar 23
DEF 14A
Definitive proxy
17 Mar 23
10-K
2022 FY
Annual report
23 Feb 23
8-K
Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 23
8-K
Regulation FD Disclosure
6 Feb 23
8-K
Regulation FD Disclosure
11 Jan 23
8-K
Amendments to Articles of Incorporation or Bylaws
28 Dec 22
8-K
Completion of Acquisition or Disposition of Assets
20 Dec 22
8-K
Entry into a Material Definitive Agreement
8 Dec 22
8-K
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027
6 Dec 22
8-K
Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027
5 Dec 22
8-K
Entry into a Material Definitive Agreement
14 Nov 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Lantheus Reports Third Quarter 2022 Financial Results
3 Nov 22
Latest ownership filings
4
Daniel Niedzwiecki
26 Apr 24
4
Paul Blanchfield
19 Apr 24
4
Andrea Sabens
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
3
Amanda Michelle Morgan
4 Apr 24
4
Robert J. Jr. Marshall
19 Mar 24
4
Andrea Sabens
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
4
Paul Blanchfield
11 Mar 24
4
Perspective Therapeutics, Inc.
8 Mar 24
SC 13D/A
Perspective Therapeutics, Inc.
8 Mar 24
4
Jean-Claude Provost
7 Mar 24
4
SAM R LENO
7 Mar 24
4
Robert J. Jr. Marshall
7 Mar 24
4
Etienne Montagut
7 Mar 24
4
Andrea Sabens
7 Mar 24
4
Paul Blanchfield
7 Mar 24
4
Daniel Niedzwiecki
7 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
4
SAM R LENO
6 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
4
Robert J. Jr. Marshall
5 Mar 24
4
Mary Anne Heino
5 Mar 24
4
Paul Blanchfield
5 Mar 24
4
Etienne Montagut
5 Mar 24
4
Jean-Claude Provost
5 Mar 24
4
Daniel Niedzwiecki
5 Mar 24
4
BRIAN A MARKISON
5 Mar 24
4
Andrea Sabens
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
4
Andrea Sabens
15 Feb 24
SC 13G
JANUS HENDERSON GROUP PLC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
144
Notice of proposed sale of securities
13 Feb 24
3
Perspective Therapeutics, Inc.
1 Feb 24
SC 13D
Perspective Therapeutics, Inc.
1 Feb 24
SC 13G/A
BlackRock Inc.
23 Jan 24